{"entity":{"id":"nct06850623","kind":"trial","name":"Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer","aka":[],"tldr":"A phase 2 trial of Acoustic Cluster Therapy in pancreatic ductal adenocarcinoma, run by EXACT Therapeutics AS, now recruiting.","summary":"Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer is a phase 2 interventional study registered as NCT06850623 by EXACT Therapeutics AS, with 25 participants planned, started 2025-06-19 and due to reach its primary completion in 2026-12-15. Interventions recorded: Acoustic Cluster Therapy and Modified FOLFIRINOX.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06850623","url":"https://clinicaltrials.gov/study/NCT06850623"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["pancreatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06850623","phase":"2","setting":"A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer","sponsor":"EXACT Therapeutics AS","enrolled":25,"outcomes":[]},"route":"/trials/nct06850623/","neighbours":{"cancer":[{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}]}}